BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29660509)

  • 1. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
    Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
    Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium ion coordinated dexamethasone supramolecular hydrogel as therapeutic alternative for control of non-infectious uveitis.
    Wu W; Zhang Z; Xiong T; Zhao W; Jiang R; Chen H; Li X
    Acta Biomater; 2017 Oct; 61():157-168. PubMed ID: 28501709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation.
    Huang J; Yu X; Zhou Y; Zhang R; Song Q; Wang Q; Li X
    Int J Pharm; 2018 Nov; 551(1-2):223-231. PubMed ID: 30213683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular nanofibers of triamcinolone acetonide for uveitis therapy.
    Li X; Wang Y; Yang C; Shi S; Jin L; Luo Z; Yu J; Zhang Z; Yang Z; Chen H
    Nanoscale; 2014 Nov; 6(23):14488-94. PubMed ID: 25341704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery.
    Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X
    Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cation instructed steroidal prodrug supramolecular hydrogel.
    Zhou Y; Lei L; Zhang Z; Zhang R; Song Q; Li X
    J Colloid Interface Sci; 2018 Oct; 528():10-17. PubMed ID: 29803956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.
    Yu X; Zhang R; Lei L; Song Q; Li X
    Int J Nanomedicine; 2019; 14():591-603. PubMed ID: 30666116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injection of triamcinolone acetonide into healthy rabbit eyes alters retinal function and morphology.
    Myers AC; Bruun A; Ghosh F; Adrian ML; Andréasson S; Ponjavic V
    Curr Eye Res; 2013 Jun; 38(6):649-61. PubMed ID: 23537282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
    Li W; He B; Dai W; Zhang Q; Liu Y
    Int Ophthalmol; 2014 Jun; 34(3):465-76. PubMed ID: 23868505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
    Roesel M; Tappeiner C; Heinz C; Koch JM; Heiligenhaus A
    Am J Ophthalmol; 2009 Mar; 147(3):406-12. PubMed ID: 19054496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
    Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina.
    Zhao M; Bousquet E; Valamanesh F; Farman N; Jeanny JC; Jaisser F; Behar-Cohen FF
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6340-7. PubMed ID: 21724913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
    Guo D; Li Q; Sun Y; Guo J; Zhao Q; Yin X; Wei H; Wu S; Bi H
    Nanotechnology; 2019 Apr; 30(16):165702. PubMed ID: 30641491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.
    Luo L; Yang J; Oh Y; Hartsock MJ; Xia S; Kim YC; Ding Z; Meng T; Eberhart CG; Ensign LM; Thorne JE; Stark WJ; Duh EJ; Xu Q; Hanes J
    J Control Release; 2019 Feb; 296():68-80. PubMed ID: 30660629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits.
    Ye YF; Gao YF; Xie HT; Wang HJ
    Mol Vis; 2014; 20():629-36. PubMed ID: 24868137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis].
    Bui Quoc E; Bodaghi B; Adam R; Burtin T; Cassoux N; Dreifuss S; Fardeau C; LeHoang P
    J Fr Ophtalmol; 2002 Dec; 25(10):1048-56. PubMed ID: 12527830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
    Yi NY; Davis JL; Salmon JH; Gilger BC
    Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.